- Salt Dental Partners adds Maryland pediatric dental group
- 9 federal government, policy updates to know
- This population doesn’t know 988 exists: 5 things to know
- 17 dentists making headlines
- Dentistry is 35% consolidated: 7 notes on the state of dental M&A
- North Carolina drops pre-approval requirement for DSO agreements
- Mass General Brigham nurses end walkout: 5 things to know
- Thomas Jefferson University to open 2nd regional medical school campus
- Experity acquires Exdion Healthcare in AI revenue cycle push
- FDA approves 1st on-body cancer drug
- The title CIOs actually want
- The 52 rural emergency hospitals by state
- Virginia system expands rehab care with new hospital
- Ex-ransomware negotiator gets 70 months for BlackCat healthcare attacks
- Minnesota AG secures refunds for patients of dental practice that closed without notice
- 2nd US citizen tests positive for Ebola: 3 outbreak updates
- New Florida ASC expands orthopedic offerings
- Anthropic’s Claude now handles healthcare claims, care management
- MSO acquires 2 physician-owned practices
- Physician among charged in $20M kickback, unnecessary prescription scheme
- Reducing orthopedic coding denials with AI — 4 takeaways
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
- Adderall Misuse Falls Sharply Among Young Adults, Study Finds
- Smartphones Can Increase Seniors' Risk Of Depression
- Pro Soccer Players Show Signs Of Shrinking Brains
- A New Option For Long-Term Care Costs
- New KFF Poll Reveals Who Is Most Likely To Endorse Vaccine Myths
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- 15 states sue US Education Department over mental health cuts
- 23 new behavioral health study findings to know
- Illinois grows certified recovery support workforce 335% since 2022
- New Mexico awards $24.5M for behavioral health expansion
- 38 behavioral health executive moves to know
- Payers are pushing top anesthesiologists out of the insurance model
- Virginia’s largest dental group adds Overjet AI platform
- My Community Dental Centers appoints chief people officer
- Former Illinois dental employee pleads guilty to stealing more than $500K from practice
- CMS’ 2027 rules: Why some specialties are ‘on the outside looking in’
- U of Maryland appoints interim dental school dean
- CMS’ ASC rule: Gains for some, cuts for others
- What leaders need to know about rising mental health leave
- CMS’ next payment move puts spine ASCs in focus
- The functions ASC leaders won’t hand off
- Washington’s noncompete ban: What healthcare employers need to know
- Doctors want wearable data but healthcare isn't ready for it, AMA survey finds
- MaineHealth launches psychiatric nurse practitioner, physician associate fellowship
- California completes statewide behavioral health shift: 3 things to know
- Feds push back HIPAA security rule overhaul to July 2027
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
- ACO REACH participants generated nearly $1B in 2024 savings: CMS
- Young people living with PKU take the mic in BioMarin podcast series, TikTok push
- Apollo inks €3B equity deal for stake in Bayer's contraceptives business
- Op-ed: Tackling affordability is a shared responsibility. Here's what hospitals are doing
- Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
- FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- A New Option for Long-Term Care Costs
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
- Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
- J&J’s Tremfya retakes ad spending throne in June as Haleon tops pharma’s World Cup airings
- Sobi earns top spot in bleeding disorder patient groups' pharma reputation rankings
- South Carolina cites behavioral health facility over missing correction plan
- Former Mayo Clinic research director sues system over alleged retaliation for raising AI practice concerns
- A $10B deal, China trial scrutiny and highlights from ADA 2026
- Memorial Hermann Health Plan winds down commercial coverage
- Remarks at the Society for Corporate Governance Conference
- CVS' Omnicare unit agrees to $440M settlement with DOJ in ongoing fraud case
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Beyond Benchmarks: Why Trust Must Be Built into Clinical AI Infrastructure
- Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
- HHS calls on hospitals to sign 'Make Hospital Food Healthier Pledge'
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- Weekly Rundown: Surgical Safety Technologies rebrands to Aimbient; UC San Diego launches applied health intelligence institute
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- How Lee Health Turned Language Access into a Strategic Clinical Asset
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- Decision readiness is the next AI advantage
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- FDA halts release of new drug rejection letters while working to formalize policy
- Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Accountability Is Key to Medicaid's Home Care Future
- Clinical Success Is No Longer One Number
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- 9 of the Top 10 Pharma Manufacturers Partner with Redi Health to Lead the Next-Generation Patient Experience
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- Regulatory tracker: NICE urges against future Lumakras reimbursement in UK
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
Michigan healthcare freedom community forum
There have been leadership changes announced at several U.S. Department of Health and Human Services (HHS) agencies:
https://thehill.com/policy/healthcare/5744237-kennedy-reshapes-hhs-leadership/
NIH director Bhattacharya to temporarily serve as CDC director
By Sophie Brams - February 18, 2026Director of the National Institutes of Health Jay Bhattacharya will serve as interim director of the Centers for Disease Control and Prevention (CDC) following the reported exit of Jim O’Neill, a Trump administration official confirmed Wednesday.
It was reported last week that O’Neill, who also served as deputy secretary of the Department of Health and Human Services (HHS), would be leaving his post as part of a broader staff restructuring within the department.
O’Neill is expected to be nominated by President Trump to lead the National Science Foundation, according to The New York Times, which first reported the news of Bhattacharya’s new role.
The shake-up at HHS comes as the Trump administration is sharpening its message on health care ahead of the midterms, hoping Secretary Robert F Kennedy Jr.’s efforts to reshape federal health policy over the past year will resonate with voters and help deliver Republican wins come November.
Other leadership shifts include Centers for Medicare and Medicaid Services (CMS) Deputy Administrator Chris Klomp taking on the role of chief counselor at HHS, and John Brooks transitioning from CMS deputy administrator and chief policy and regulatory officer to CMS senior counselor.
At the Food and Drug Administration (FDA), Deputy Commissioners Kyle Diamantas and Grace Graham were also given new posts as senior counselors.
“In just over a year, we have driven historic progress on President Trump’s health care priorities and delivered real, measurable change,” Kennedy said in a Feb. 12 statement announcing the changes.
“We are restoring accountability, challenging entrenched interests, and putting the health of the American people first. I am proud to elevate battle-tested, principled leaders onto my immediate team—individuals with the courage and experience to help us move faster and go further as we work to Make America Healthy Again,” he added.
The CDC itself has seen abrupt leadership changes over the past year, including the ouster of Director Susan Monarez last August, who was fired less than a month into the job after she refused pressure from the White House to resign.
Bhattacharya, a Stanford University professor, is now poised to take the helm at a time when the agency has come under scrutiny for its shifts to vaccination policies and recommendations.
He said during a Senate hearing last week that he had not seen any studies supporting a potential connection between any vaccine and autism, disputing a theory often peddled by Kennedy.
Bhattacharya is slated to serve as interim director until the U.S. Senate confirms a permanent successor.
After falsely savaging Dr. Jay Bhattacharya during the pandemic, the health care Deep State is now terrified of him:
https://thehill.com/policy/healthcare/5748218-bhattacharya-cdc-nih-leadership-concern/
Bhattacharya’s growing power in Trump’s HHS worries health experts
By Joseph Choi - February 22, 2026Public health experts and former federal staffers are uneasy over National Institutes of Health (NIH) Director Jay Bhattacharya’s rising influence over U.S. health policy as he temporarily takes on the added role of leading the Centers for Disease Control and Prevention (CDC).
The Trump administration announced the leadership shake-up this week, with former interim CDC Director Jim O’Neill being moved out of the Department of Health and Human Services (HHS).
“Candidly, this is someone who very clearly has an ax to grind with science and the scientific community in general,” Kayla Hancock, director of Protect our Care’s Public Health Watch project, said of Bhattacharya.
“We’ve seen with his record already at NIH and his history of Covid denialism before he even took this office that this is just not the kind of person that we need at the helm of our key public health and medical research institutions.”
Bhattacharya, confirmed as NIH director in March of last year, was a Stanford University professor of medicine before joining the Trump administration. He was also one of the lead authors of “Great Barrington Declaration,” a 2020 open letter calling for COVID-19 lockdowns to be rolled back.
In an email to CDC staff on Friday, Bhattacharya laid out what he said was a plan to restore trust in public health. During the pandemic, he wrote, it was “undeniable that some of the Federal government’s decisions, communications, and processes contributed to confusion, frustration, and a loss of that trust.”
“I also recognize the unique challenges faced by each of you over the past year due to abrupt changes in leadership, the tragic act of violence last summer, and overall uncertainty felt by all of you,” wrote Bhattacharya, referring to the fatal shooting at the CDC’s headquarters last year. “One of my goals is to ensure that you all get the recognition you deserve for your efforts.”
He listed three principles the agency would follow under his rule: updating guidance “transparently” as new data emerges, ensuring every investigation it conducts reflects the “responsibility to the communities we serve” and strengthening internal review processes to enhance “accountability and openness.”
The position of CDC director has been haphazardly filled over the past year. President Trump’s first pick, former Florida Rep. David Weldon (R), failed to gain support in the Senate, leading to longtime federal scientist Susan Monarez, the interim director, receiving the nomination to fill the role permanently.
Monarez was ultimately confirmed by the Senate along party lines, but only weeks later the administration pushed her out, with her claiming it was due to her refusal to give blanket approval of recommendations from the CDC’s Advisory Committee on Immunization Practices, which Health and Human Services Secretary Robert F. Kennedy Jr. had restaffed with ideological allies.
O’Neill, a deputy HHS secretary, was then made the interim director, making Bhattacharya the third acting CDC director in seven months.
Former CDC physician Elizabeth Soda, who resigned late last year, said the American public is suffering because of the lack of stable leadership within the agency.
She noted how Congress had largely maintained funding for the agency, rejecting calls by the administration to deeply cut appropriations, indicating the legislative branch recognizes the importance of a strong CDC.
“How can you even do the work that they’re being given the money to do, right? That’s a big challenge, and without having clear leadership, who can really devote the time and energy and expertise to face these challenges head on?” Soda said.
Former federal staffers and public health voices who spoke with The Hill said the NIH and CDC agencies are too large and distinct from one another to have one individual leading both at the same time.
“I don’t think Jay Bhattacharya can be trusted to lead either. But I think the size of both of these organizations and the missions are different, and I think it takes a specific type of person, a single person, to do each of these jobs,” said James Alwine, coordinating committee member of the nonprofit volunteer network Defend Public Health and professor emeritus of cancer biology at the University of Pennsylvania School of Medicine.
The NIH’s primary objective is to support U.S. research infrastructure, while the CDC is largely tasked with surveilling and addressing disease threats.
Alwine began his career at the NIH. He opined that Bhattacharya’s motivations to lead these agencies did not align with their missions of promoting and protecting public health.
“I think some of the things he’s doing certainly look to me like he’s getting back at those who came down on him because they criticized him so much about the Great Barrington Resolution,” Alwine said.
When reached for comment, HHS spokesperson Emily Hilliard said of Bhattacharya, “The Director has empowered the NIH leadership team to ensure the agency’s priorities continue moving forward until the President nominates and the Senate confirms a permanent CDC director.”
“CDC Principal Deputy Director Ralph Abraham and other members of the CDC leadership team will work closely with Dr. Bhattacharya during this acting period to continue protecting and serving the American people,” Hilliard added. “The Director is solely focused on ensuring a seamless transition for both agencies while maintaining continuity of leadership and advancing their core public health missions.”
Monarez, the only confirmed CDC director in Trump’s second term, was an outlier when it came to health nominees. She did not come from the “Make America Healthy Again” (MAHA) antiestablishment world that many of Kennedy’s picks came from, having been a government scientist for decades.
Her refusal to bend completely to the MAHA agenda seemingly played a significant part in her termination.
With Bhattacharya’s temporary dual role, public health influence has become further consolidated among ardent Kennedy allies. Whether Trump and Kennedy can find a MAHA ally who can also win Senate confirmation as CDC director remains to be seen.
Soda, the former CDC staffer, was hopeful that compromises could be made for the sake of stable leadership at the agency.
“The optimist in me can hope,” Soda said. “We have to come to some middle ground understanding with one another, where we may not fully agree completely. But wouldn’t it be great if we could try to start moving towards the middle.”
“In some ways, MAHA’s beliefs, I think, are just so contrary to what CDC represents,” Soda added. “It would be difficult, I think, to find someone who’s a true sort of believer in those principles to also then come and successfully lead the agency that is, you know, the agency that is driven by scientific evidence and data.”
😎 Coming to a theater near you: Jay Bhattacharya, the movie!
https://www.politico.com/news/2026/02/22/the-next-hollywood-hero-jay-bhattacharya-00791313
RFK Jr.’s billionaire running mate is making a comedy about the pandemic
Nicole Shanahan has recruited a top screenwriter and enlisted Covid contrarian Jay Bhattacharya.
By Kelly Hooper - February 22, 2026Covid contrarians tight with Robert F. Kennedy Jr. are pitching Hollywood on an unlikely leading man: National Institutes of Health Director Jay Bhattacharya.
Nicole Shanahan, Kennedy’s running mate in the 2024 presidential campaign, is searching for investors to fund a movie that pokes fun at the pandemic response with a star based on Bhattacharya, who rose to prominence with his anti-lockdown manifesto and relentless tweets opposing social distancing.
The script for the satirical comedy, “The Rash,” is by renowned author Walter Kirn, who wrote the novel “Up in the Air” that became an Oscar-nominated movie starring George Clooney. The new Kirn screenplay stars a “no-nonsense” public health professor at a Stanford-like California university — mirroring Bhattacharya — who speaks out against mass hysteria amid a mysterious outbreak of a contagious skin condition.
The story of the pandemic is one “of great heroes who stood up and said no” to “dangerous scientific experiments mixed with misleading propaganda, mass psychosis, and outright lies,” says the Brownstone Institute in a recent appeal sent to potential funders of the film.
The think tank that once counted Bhattacharya as a senior scholar added that “investors are terrified of the topic and Hollywood elites don’t even want it made.”
The push to make the film is among numerous examples, since President Donald Trump returned to office, in which the president or his allies have sought approbation from America’s culture-making institutions. They’ve had some success. Trump allies renamed the Kennedy Center in Washington to honor him in December and Amazon released a film last month about first lady Melania Trump.
Since 2020, a number of figures in Trump’s orbit have been involved in the creation and promotion of films criticizing public officials’ response to the pandemic or pushing fringe theories about it or vaccines.
Jeffrey Tucker, Brownstone’s founder and president, didn’t respond to requests for comment. In October 2020, he convened a group of scientists, including Bhattacharya, who wrote the Great Barrington Declaration opposing Covid lockdowns. It set off a vigorous debate about the pandemic response and prompted Bhattacharya’s predecessor at NIH, Francis Collins, to call him a “fringe epidemiologist.”
Bhattacharya, whom Kennedy also named acting director of the Centers for Disease Control and Prevention on Wednesday, is on board with the movie, an NIH spokesperson told POLITICO.
“Dr. Bhattacharya has spoken positively about the work Walter Kirn is doing, noting that the project reflects a strong commitment to free speech and open inquiry, and he welcomes thoughtful creative efforts that engage with these issues,” the spokesperson said.
Bhattacharya declined to comment. He’s spent at least 10 hours speaking to Kirn, who shares his views on the handling of the pandemic, for the film.
Shanahan is an executive producer of “The Rash” along with her partner, Jacob Strumwasser, according to Brownstone. Neither Shanahan nor Strumwasser could be reached for comment. Shanahan, a lawyer and entrepreneur, is reportedly a billionaire following her divorce three years ago from Google founder Sergey Brin. While married to Brin, she founded a philanthropy that focuses on extending women’s fertility.
Funding for “The Rash” nonetheless remains an obstacle. The estimated production budget is close to $6 million, according to a slide deck on Brownstone’s website.
Brownstone “is well-positioned to be a fiscal sponsor of this effort,” and the project “already has a top production company lined up along with some notable talent to make a first-rate film,” the website says.
In September, Kirn released a short teaser trailer for “The Rash” on social platform X, saying the film is in the financing phase and interested investors should contact him.
Kirn did not respond to a request for comment.
He said in the X post that he wrote the film for Shanahan and 0nset Creative, an independent production company founded by Alex Lee Moyer, a filmmaker whose credits include a 2022 documentary on far-right conspiracy theorist Alex Jones. In September, as a guest on Shanahan’s podcast, Moyer described the Jones documentary as a film about Covid, the “runway to Jan. 6” and “how off the rails the world went during that moment.”
Three pages of the script for “The Rash” are previewed on Brownstone’s website. In one scene, the governor of California and a character named Dr. Roman Fox orchestrate a celebrity singalong amid the outbreak. A “succession of celebs sing lines from the song ‘Aquarius’ by the Fifth Dimension,” the script reads.
“Some sing beautifully, some not,” the screenplay says. “Behind them are their yards and homes. One sings naked with his crotch blurred out, his body gleaming with oil.”
The song, a No. 1 hit in 1969 based on numbers from the musical Hair, previews a time when Jupiter aligns with Mars and “peace will guide the planets and love will steer the stars.”
The scene appears to poke fun at a celebrity singalong of the John Lennon song “Imagine” during the early days of the Covid pandemic, spearheaded by actress Gal Gadot. At the time, the viral video was widely criticized as elitist and out of touch.
0nset Creative was “established in response to a landscape where media has become decentralized and old models are buckling under the weight of the times,” its website says. The studio is working on a handful of other projects in addition to “The Rash,” including “the first in depth documentary about Silicon Valley and its denizens” and another documentary on unidentified flying objects.
During the September podcast interview with Moyer, Shanahan said she and her partner, Strumwasser, had the “stupid idea” for a satire film inspired by the Covid pandemic and decided to run with it.
“We were like, ‘Wouldn’t it be great if we could just laugh about how ridiculous this all was and how awful it all was?’ But also laugh at it because that means that it’s in the past,” she said.
Moyer said Shanahan approached 0nset Creative with the idea.
“I got to thinking, ‘Well, who’s the best person who can work on this? Who can write a script that’s worthy of this topic?’ And I thought of my good friend, Walter Kirn,” said Moyer.
Shanahan and Strumwasser gave Kirn creative liberty to tell the story in the way he wanted, and he came back with the script for “The Rash,” Moyer added.
Moyer said “The Rash” reminds her of conspiracy thrillers from the ‘60s and ‘70s like “Dr. Strangelove” and “Network,” as well as “some of the lighter influences from films in the ‘90s” like “Wag the Dog” and “Thank You for Smoking.”
“We need to be able to have a sense of humor about our collective trauma,” Moyer told Shanahan.
0nset Creative did not respond to a request for comment, and Moyer could not be reached.
A second scene in the script features a conversation between Fox and “Dr. Neal Chandra,” the character based on Bhattacharya. Fox declares “I’m the science” during the scene — an apparent reference to a 2021 interview in which Anthony Fauci, who led the U.S. pandemic response, said his critics were “really criticizing science because I represent science.” Fox encourages Chandra to sign a document supporting that statement. Chandra refuses.
In a description of the film’s cinematography, the slide deck on Brownstone’s website says the movie will “toggle between composed shots that reflect Dr. Chandra’s rational perspective and looser, handheld coverage that captures the surrounding chaos: influencers melting down on livestreams, press conferences spinning off-script, executives high on their own power.”
“The world bends while Chandra stands still,” the description reads.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























